Igniting Hope: 360° Recruitment & Digital Breakthroughs Accelerate Alzheimer's Trials!

Clinical TrialsTherapueticsFDA
Written By Corey Hubbard
Igniting Hope: 360° Recruitment & Digital Breakthroughs Accelerate Alzheimer's Trials!
Glassbury Team

GlassBury Cares Podcast

Episode #27

Corey Hubbard
Previous

Nuvectis Pharma's Bold Pivot: NXP800 Exits Ovarian Cancer, NXP900 Leads New Oncology Frontier
Next

The Robust and Diverse Future of Alzheimer's Drug Development in 2025